A Randomized, Double-Blind Placebo-Controlled, Parallel Group Study to Study the Efficacy and Tolerability of Ramelteon (Rozerem) in the Prophylaxis of Migraine.

Trial Profile

A Randomized, Double-Blind Placebo-Controlled, Parallel Group Study to Study the Efficacy and Tolerability of Ramelteon (Rozerem) in the Prophylaxis of Migraine.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 09 Jun 2013

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Aug 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 05 Oct 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
    • 05 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top